Plain-English translation of NCT07168200 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing a medication called Adebrelimab combined with the standard treatment (chemotherapy and radiation) for locally advanced cervical cancer. Half of the participants will receive the medication plus standard treatment, and the other half will receive a placebo (a dummy pill with no active drug) plus standard treatment. The study will measure how well the medication helps prevent the cancer from coming back or growing.
Cervical cancer that has spread locally (to nearby tissues and lymph nodes) can be hard to treat with current therapies alone. Researchers believe that this medication, which helps boost the immune system to fight cancer cells, may work better when combined with chemotherapy and radiation.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to receive either the new medication or a placebo, both combined with standard chemotherapy and radiation therapy. Throughout the study, you'll visit the clinic regularly for treatment sessions, blood tests, and scans to monitor how well the treatment is working and to check for side effects. The study will track how long it takes for your cancer to progress and will continue monitoring your health to see which approach works better.
AI-generated summary from trial data · Jul 3, 2026 · Not medical advice
China